STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
M.D. Anderson Cancer Center
Psyence Australia Pty Ltd
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
MacroGenics
Daiichi Sankyo
ImmunityBio, Inc.
City of Hope Medical Center
Mayo Clinic
Incyte Corporation
National Cancer Institute (NCI)
Mayo Clinic
Yale University
University of Pittsburgh
M.D. Anderson Cancer Center
Tempus AI
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Oslo University Hospital
Merck Sharp & Dohme LLC
Incyte Corporation
Seagen Inc.
University of California, San Diego
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Children's National Research Institute
Innovent Biologics (Suzhou) Co. Ltd.
ImaginAb, Inc.
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
ImaginAb, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
Exelixis
National Cancer Institute (NCI)
Incyte Corporation
Eastern Cooperative Oncology Group
Qilu Pharmaceutical Co., Ltd.
Jules Bordet Institute
University College, London
Duke University
TC Biopharm
MultiVir, Inc.
Loma Linda University
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
St. Louis University
National Institutes of Health Clinical Center (CC)